Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
We compare the 2024 outlook for index funds and target date funds to help you choose the right retirement path.
23,982 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
U.S. inflation climbs above 4% for the first time since 2023, renewing pressure on the Fed and prompting traders to r...
A fintech founder chose financial discipline over prestige, turning down an invitation from President Obama to focus ...
A U.S. Polo Assn. CEO faced a promotion snub, then outworked every competitor for six months to seize the role and dr...
Chief sustainability officers pitch climate action as a business investment tied to cash flow and risk management. CE...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
A sharp upgrade, new AI partnerships, and a strategic move to Miami illuminate Palantir's potential. Learn how these ...
This article dives into amerisafe (amsf) 2025 earnings expectations, outlining key drivers, potential pitfalls, and a...
A Wisconsin man receives a seven-year prison term for arson linked to opposition to a TikTok policy. The case undersc...
New wage data in early 2026 shows the payoff from switching jobs is fading. Movers earned roughly 4% in January, whil...
U.S. authorities charged Supermicro co-founder Yih-Shyan Liaw and two associates with orchestrating a multi-billion-d...
Gabe Bodner, a veteran lender now leading OneTrust Home Loans' reverse mortgage unit, outlined a branding-focused str...